Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Clinical trial NCT03154515 · COMPLETED

Trial details

NCT number: NCT03154515
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Common Cold Influenza, Human Acute Respiratory Infection

Start date: 2010-01-01
Primary completion: 2014-04-01
Enrollment: 445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.